• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of March 29

Video

Here are the top 5 biosimilar articles for the week of March 29, 2021.

Hi, I’m Skylar Jeremias for The Center for Biosimilars®, your resource for clinical, regulatory, business, and policy news in the rapidly changing world of biosimilars.

Here are the top 5 biosimilar articles for the week of March 29, 2021.

Number 5: Samsung Bioepis is reporting that its adalimumab biosimilar Hadlima has been launched in Australia.

Number 4: EirGenix, in partnership with Sandoz, announced positive safety and efficacy results for its trastuzumab biosimilar in patients with breast cancer.

Number 3: Biosimilars get short shrift in a proposed pricing model developed by the Drug Pricing Lab at Memorial Sloan Kettering (MSK), experts say.

Number 2: A panel of physicians gave advice on how biosimilar educational materials should instill confidence in these medications and which policies may be more harmful than beneficial.

Number 1: A renowned expert on the life sciences industry in the United Kingdom provides an insightful look at Brexit and the importance for the pharmaceutical sector.

To read all of these articles and more, visit centerforbiosimilars.com.

Related Videos
Here are the top 5 biosimilar articles for the week of June 17, 2024.
Here are the top 5 biosimilar articles for the week of June 10, 2024.
Lakesha Farmer, PharmD
The Top 5 Biosimilar Articles of the Week.
Here are the top 5 biosimilar articles for the week of May 27, 2024.
Lakesha Farmer from Cencora
Here are the top 5 biosimilar articles for the week of May 20, 2024.
Here are the top 5 biosimilar articles for the week of May 13, 2024.
Related Content
© 2024 MJH Life Sciences

All rights reserved.